Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [4199]

SABCS 2017: Phase III EMBRACA trial meets primary PFS endpoint

SABCS 2017: Phase III EMBRACA trial meets primary PFS endpoint

SABCS 2017: Circulating tumour cells may predict late recurrence in HR-positive breast cancer patients

SABCS 2017: Circulating tumour cells may predict late recurrence in HR-positive breast cancer patients

SABCS 2017: Older women with HR-positive breast cancer may receive similar benefit from CDK 4/6 inhibitors as younger women

SABCS 2017: Older women with HR-positive breast cancer may receive similar benefit from CDK 4/6 inhibitors as...

SABCS 2017: Postmenopausal women who lose weight may have reduced breast cancer risk

SABCS 2017: Postmenopausal women who lose weight may have reduced breast cancer risk

SABCS 2017: Phase III trial data supports current standard 12-month adjuvant trastuzumab for HER2-positive breast cancer

SABCS 2017: Phase III trial data supports current standard 12-month adjuvant trastuzumab for HER2-positive breast...

SABCS 2017: Two years of extended anastrazole therapy as effective as five

SABCS 2017: Two years of extended anastrazole therapy as effective as five

SABCS 2017: Temporary ovarian suppression with hormone analogue may preserve fertility during breast cancer chemotherapy

SABCS 2017: Temporary ovarian suppression with hormone analogue may preserve fertility during breast cancer...

SABCS 2017: Acupuncture significantly reduces joint pain for breast cancer patients

SABCS 2017: Acupuncture significantly reduces joint pain for breast cancer patients

SABCS 2017: Contrast-enhanced digital mammography comparable to breast MRI after therapy or chemo

SABCS 2017: Contrast-enhanced digital mammography comparable to breast MRI after therapy or chemo

Diabetes drug metformin inhibits multidrug-resistant breast cancer

Diabetes drug metformin inhibits multidrug-resistant breast cancer

More from ecancer